Celltrion Inc (068270) – Strategy, SWOT and Corporate Finance Report
- Pages: 47
- Published: May 2023
- Report Code: MLPH16517FSA
Celltrion Inc (068270) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Celltrion Inc (Celltrion) is a biopharmaceutical company that focuses on the research, development, and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn’s disease, psoriatic arthritis, and psoriasis. Its pipeline portfolio spans monoclonal antibody biosimilars for the treatment of rheumatoid arthritis; colorectal cancer; and respiratory disease; and antibody biologics and vaccines for infectious diseases such as hepatitis B, influenza, rabies, breast cancer, and seasonal influenza. Celltrion develops drugs by using its bioengineering and mammalian cell-culture technology. The company also carries out contract manufacturing of biosimilars. It has an operational presence in Korea, Russia, the UK and the US. Celltrion is headquartered in Incheon, South Korea.
Scope
• Detailed information on Celltrion Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Celltrion Inc in the form of a SWOT analysis
• An in-depth view of the business model of Celltrion Inc including a breakdown and examination of key business segments
• News about Celltrion Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Celltrion Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Celltrion Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Celltrion Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Peptron Inc
Helixmith Co Ltd
Biosolution Co Ltd
Seoul Pharma Co Ltd
JW Pharmaceutical Corp
ChoongAng Vaccine Laboratory
Genexine Inc
ChoongAng Vaccine Laboratory
Helixmith Co Ltd
Peptron Inc
Seoul Pharma Co Ltd
JW Pharmaceutical Corp
Genexine Inc
Biosolution Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.